DxPx Conference 2025: International Investor Conference hosting the 42plus1 Business Plan Competition with up to $2 Million in Funding

For the 6th time, the European DxPx Conference will take place from January 26-27, 2025, in Munich, providing startups, investors, and established companies with an exceptional platform for networking and partnerships. The conference has established itself as a leading international investor platform for diagnostics, digital health, personalized medicine, and life science tools, attracting participants from around the world. "We believe DxPx to be the best investor conference for diagnostics, digital health and life science tools. We actively encourage startups to participate to meet relevant investors and network within this community," explains Louise Warme, Head of We Venture Capital, the corporate venture arm of the global diagnostics company Werfen.

42PLUS1 Pitch Award: A Launchpad for Groundbreaking Innovations

A key highlight of the 2025 event in Munich is the 42PLUS1 Pitch Award, which will put innovative startups in the spotlight and offer them the opportunity to meet approximately 100 investors. This competition offers emerging companies in diagnostics, digital health, and life sciences tools the chance to present their disruptive business ideas and technologies to a global audience of investors, industry experts, and decision-makers. The three winners of the 42PLUS1 Pitch Award qualify-pending a due diligence review-for an investment of up to $2 million and the chance to work with leading investors and mentors to drive their company's growth.
Startups can apply for the pitch competition until November 22, 2024. The eight finalists will be announced at the end of December, granting them a unique opportunity to present their ideas live on stage and make valuable connections that could pave the way for future success. Participation requirements can be found at www.42plus1.com.

Networking, Startup City, and Investor Partnering

The DxPx Conference also offers extensive one-on-one partnering opportunities, enabling startups and companies to connect with investors and potential partners. These tailored discussions are ideal for exploring innovative collaborations and investment opportunities. Additionally, panel discussions and keynote presentations provide insights into the latest developments shaping the future of the life sciences industry. Furthermore, twenty selected startups will be able to showcase their innovations in the "Startup City."
Workshops and Expert Lectures
Participants of the DxPx Conference can also attend a variety of workshops and expert lectures addressing current topics and challenges in the industry. Leading experts share their insights and offer practical solutions for companies working in life sciences and diagnostics.

Participation and Registration
The DxPx Conference is aimed at startups, scaleups, investors, and companies in the life sciences and healthcare sectors seeking new business opportunities and insights into the latest industry innovations. Interested parties can register for the event in Munich on the DxPx website and also find information on applying for the 42PLUS1 Pitch Award.

Conference Venue
Leonardo Royal Munich
Moosacher Straße 90 | 80809 München Company Contact

SLS Partnering GmbH Dr. Mirko Stange Brunnenstraße 23 | 40223 Düsseldorf
Phone: +49 211 302 708 13 Fax: +49 211 302 708 29 info@sls-partnering.com Press Contact .FACTUM - Ehrliche Kommunikation GmbH Kathrin Hecht Leopoldstraße 54 | 80802 München
Phone: +49 89 8091317-44
Fax: +49 89 8091317-90
hecht@factum-pr.com

About the DxPx Conference
Since its founding in 2014, the DxPx Conference has established itself as an internationally leading platform for exchange between investors and companies in the life sciences industry. The conference is held in Europe and North America, offering participants a unique opportunity to explore business opportunities and forge strategic partnerships.

This release was published on openPR.